Добірка наукової літератури з теми "Cancer pain Chemotherapy"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cancer pain Chemotherapy".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cancer pain Chemotherapy"
Hancock, E. William. "Chest Pain During Cancer Chemotherapy." Hospital Practice 20, no. 7 (July 15, 1985): 93–97. http://dx.doi.org/10.1080/21548331.1985.11703097.
Повний текст джерелаSavage, L. "Chemotherapy-Induced Pain Puzzles Scientists." JNCI Journal of the National Cancer Institute 99, no. 14 (July 10, 2007): 1070–71. http://dx.doi.org/10.1093/jnci/djm072.
Повний текст джерелаChoi, Kyomin, and Jeeyoung Oh. "Peripheral Neuropathy and Pain Caused by Cancer Chemotherapy." Journal of the Korean Neurological Association 39, no. 1 (February 1, 2021): 1–9. http://dx.doi.org/10.17340/jkna.2021.1.1.
Повний текст джерелаYosra, Yahyaoui, Ghorbel Achref, Charfi Lamia, Gamoudi Ahmed, Gabsi Azza, and Mezlini Amel. "Low Grade Abdominal Leiomyosarcoma with Liver Metastasis: A Second Cancer Twenty Years after Treatment for Nasopharyngeal Cancer." Clinical Oncology Research and Reports 1, no. 2 (November 16, 2020): 01–03. http://dx.doi.org/10.31579/2693-4787/015.
Повний текст джерелаFonte, Carlos E., and Frank Cardello. "Chest Pain in a Cancer Patient on Chemotherapy." Hospital Practice 26, no. 7 (July 15, 1991): 145–46. http://dx.doi.org/10.1080/21548331.1991.11704212.
Повний текст джерелаBanipal, R. P. S., and M. K. Mahajan. "Methotrexate Revisited—in Recurrent Head and Neck Cancer." Palliative Care: Research and Treatment 5 (January 2011): PCRT.S6107. http://dx.doi.org/10.4137/pcrt.s6107.
Повний текст джерелаLin, Jaung-Geng, and Yi-Hung Chen. "The Role of Acupuncture in Cancer Supportive Care." American Journal of Chinese Medicine 40, no. 02 (January 2012): 219–29. http://dx.doi.org/10.1142/s0192415x12500176.
Повний текст джерелаCoffeen, Ulises, Marco Antonio Sotomayor-Sobrino, Ariadna Jiménez-González, Luis Gerardo Balcazar-Ochoa, Pamela Hernández-Delgado, Ana Fresán, Ricardo Plancarte-Sánchez, Daniela Arias-Muñoz, and Abraham Ochoa-Aguilar. "Chemotherapy-induced neuropathic pain characteristics in Mexico’s National Cancer Center pain clinic." Journal of Pain Research Volume 12 (May 2019): 1331–39. http://dx.doi.org/10.2147/jpr.s186107.
Повний текст джерелаRamaekers, Ryan C., Jon Olsen, Angela Mae Obermiller, Melhem Salim Jabbour, Mark Tharnish, Megan Schriner, Rita Hays, et al. "Efficacy and safety of half-dose pegfilgrastim in cancer patients receiving cytotoxic chemotherapy." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 9110. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9110.
Повний текст джерелаVenkata Durga, Vinoothna Thelkar, Parineethi Karanam, Jyoshna Pisini Vyshnavy, Sadasiva Rao Galaba, and Srikanth Boga. "Pain Assessment in Breast Cancer Patients." Journal of Pharmaceutical Quality Assurance and Quality Control 4, no. 1 (June 29, 2022): 27–34. http://dx.doi.org/10.46610/jqaqc.2022.v04i01.006.
Повний текст джерелаДисертації з теми "Cancer pain Chemotherapy"
Jeon, Sangchoon. "Factors associated with time to resolution of pain and fatigue among cancer patients undergoing chemotherapy in a cognitive behavioral intervention group." Diss., Connect to online resource - MSU authorized users, 2006.
Знайти повний текст джерелаHellerstedt-Börjesson, Susanne. "Smärta vid adjuvant cytostatikabehandling : Uppfattningar och inverkan på dagligt liv hoskvinnor diagnostiserade med bröstcancer." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-156063.
Повний текст джерелаDagens adjuvanta cytostatikabehandlingav kvinnor med bröstcancer kan leda till smärta. Denna studies syfte var att undersöka olikauppfattningar om inverkan av smärta, utlöst av adjuvant cytostatikabehandling,på dagligt liv hos några kvinnor som nyligen diagnostiserats med bröstcancer.Inklusionskriterier var deltagande i ett pågående stresshanteringsprojekt ochcytostatikabehandling i doser om 75mg² eller mer av antracyklin och/ellertaxan. Exklusionskriterier var oförmåga att förstå och kommunicera på svenska ochpsykisk sjukdom. Efter etiskt godkännande av delstudien i september 2010 inkluderades kvinnorna konsekutivt genommuntlig och skriftlig förfrågan. Fenomenologisk ansats användes i de åttaintervjuerna och i resultatbearbetningen. Resultatet kom att utgöras av fembeskrivningskategorier: den förklarliga smärtan, den övervinneliga smärtan, denensamma smärtan, den ofattbara smärtan och sist den förlamande smärtan.Tillvaron var öppen då smärtankändes förklarbar och därmed hanterbar, medan den slöts när smärtan kändesoförklarlig och kvinnornas liv förändrades drastiskt. Studien visar på en betydande smärtinverkan vid cytostatikabehandling. Kvinnornafick svårt att referera till den av sjukvården givna informationen, när smärtangick utanför tidigare beskrivning och smärtupplevelser. Det fanns en tendensatt kvinnan avvaktade innan hon kontaktade sjukvården och i denna väntanuppstod svåra tankar och känslor. En fråga för vidare forskning är hurpersonalen kan fånga upp och bättre hjälpa de kvinnor som får svåra smärtor.
Lin, Shu-Fen, and 林淑棻. "Pain,Depression and Quality of Sleep in Lung Cancer Patients during Chemotherapy." Thesis, 2008. http://ndltd.ncl.edu.tw/handle/88063119741884307947.
Повний текст джерела長庚大學
護理學研究所
96
The purpose of this study was to explore the longitudinal change in and relationship among pain, depression, and sleep quality in lung cancer patients treated with chemotherapy. A total of 116 patients with lung cancer were recruited. Patients completed Brief Pain Inventory (BPI, Hospital Anxiety and Depression Scale(HADS), and Pittsburgh Sleep Quality Index (PSQI) at pre-chemotherapy and at the 15th day of every chemotherapy cycle for 6 cycles. Data were analyzed using descriptive statistic, Pearson correlation and mixed effect models. The study results showed: (1) the average pain levels were mild through out six chemotherapy cycles with pre-chemotherapy level being the highest. (2) Most of the patients were not depressed through out six chemotherapy cycles. Depressive scores were high at pre-chemotherapy but gradually decreased through out the chemotherapy cycles. Depressive scores at pre-chemotherapy and the 1st cycles were significantly higher than other cycles. (3) During days when chemotherapy was given, sleep quality were continuously worsen from the 2nd to the 5th cycles. During days when chemotherapy was not given (rest period), sleep quality was poor at the 1st cycle and improved at the 2nd and 3rd cycle, then fluctuated at the 4th and 6th cycles; the sleep quality at pre-chemotherapy and the 1st cycle was significantly poorer than that of other cycles. (4) Significant correlations were found between average pain level and sleep quality at the 4th and 6th cycles and between depression and sleep quality at all cycles. (5) Income had significant effect on sleep quality; patients with low income had poorer sleep quality. (6) During days when chemotherapy was given, there was a significant interaction effect on sleep quality between type of chemotherapy agent and time. The sleep quality for patients treated with traditional chemotherapy agents was deteriorate over time; but for patients treated with new drugs (e.g., target therapy), the sleep quality tended to improve over time.
(8766597), Parul Verma. "Towards Understanding Neuropathy from Cancer Chemotherapy and Pathophysiology of Pain Sensation: An Engineering Approach." Thesis, 2020.
Знайти повний текст джерелаThe following paragraphs reflect the organization of this thesis. Each paragraph introduces a research problem, the approaches taken to investigate it, and states the key results.
First, a metabolomics-based approach was used to investigate CIPN prediction. Blood samples of pediatric leukemic cancer patients who underwent treatment with a chemotherapy agent - vincristine were provided. These blood samples were analyzed at different treatment time points using mass spectrometry to obtain the metabolite profiles. Machine learning was then employed to identify specific metabolites that can predict overall susceptibility to peripheral neuropathy in those patients at specific treatment time points. Subsequently, selected metabolites were used to train machine learning models to predict neuropathy susceptibility. Finally, the models were deployed into an open-source interactive tool- VIPNp- that can be used by researchers to predict CIPN in new pediatric leukemic cancer patients.
Second, the focus was shifted to the pathophysiology of pain and the pain-sensing neuron; specifically: (i) investigating pain sensation mutations and the dynamics of the pain-sensing neuron, and (ii) exploring chemotherapy-induced peripheral neuropathy mechanisms.
While pain is a common experience, genetic mutations in individuals can alter their experience of pain, if any at all (certain mutations yield individuals insensitive to pain). Despite its ubiquity, we do not have a complete understanding of the onset and/or mechanisms of pain sensation. Pain sensation can be broadly classified into three types: (i) nociceptive, (ii) neuropathic, and (iii) inflammatory. Nociceptive pain arises due to a noxious external stimulus (e.g., upon touching a hot object). Neuropathic pain (which is felt as a side-effect of the aforementioned chemotherapy agents) is the numbing and tingling sensation due to nerve damage. Inflammatory pain occurs due to damage to internal tissues. Pain in any form can be characterized in terms of electrical signaling by the pain-sensing neuron. Signal transmission regarding pain occurs through generation of an electrical signal called the action potential- a peak in neuron membrane potential. Excessive firing of action potentials by a pain-sensing neuron indicates pain of a specific form and intensity. In order to investigate this electrical signaling, a mathematical modeling approach was employed. The neuron membrane was assumed to be an electrical circuit and the potential across the membrane was modeled in terms of the sodium and potassium ions flowing across it via voltage-gated sodium and potassium channels, respectively. Generation of a single action potential followed by a resting state corresponds to a normal state, whereas periodic firing of action potentials (an oscillatory state) corresponds to pain of some form and intensity in vitro. Therefore, an investigation into the switch from a resting state to an oscillatory state was proposed. A bifurcation theory approach (generally useful in exploring changes in qualitative behavior of a model) was used to explore possible bifurcations to explain this switch. Firstly, genetic mutations that can shift the pain sensation threshold in the pain-sensing neuron were explored. The detected bifurcation points were found to be sensitive to specific sodium channels’ model parameters, implying sodium channels’ sensitivity towards the pain sensation threshold. This was corroborated by experimental evidence in existing literature. Secondly, a theoretical analysis was performed to explore all possible bifurcations that can explain the dynamics of this pain-sensing neuron model. The mathematical modeling simulations revealed a mixture of small amplitude and large amplitude membrane potential oscillations (mixed-mode oscillations) for specific parameter values. The onset and disappearance of the oscillations were investigated. Model simulations further demonstrated that the mixed-mode oscillations solutions belonged to Farey sequences. Furthermore, regions of bistability- where stable steady state and periodic solutions coexisted- were explored. Additionally, chaotic behavior was observed for specific model parameters.
Finally, this thesis investigated the role of voltage-gated ion channels in inducing CIPN using the same mathematical model. Repetitive firing of action potentials in the absence of any external stimulus was used as an indicator of peripheral neuropathy. Bifurcation analysis revealed that specific sodium and potassium conductances can induce repetitive firing without any external stimulus. The findings were supplemented by recording the firing rate of a sensory neuron culture. Next, a chemotherapy agent - paclitaxel, was introduced in the model to investigate its potential effects on the firing behavior. It was seen that a medium dose of paclitaxel increased repetitive firing. This was supported by the firing rate recordings of the sensory neuron culture.
In summary, this thesis presents a prediction strategy for CIPN. Moreover, it presents a bifurcation theory-based framework that can be used to investigate pain sensation, in particular, genetic mutations related to pain sensation and chemotherapy-induced peripheral neuropathy. This framework can be used to find potential voltage-gated ion channels that can be targeted to control the pain sensation threshold in individuals, and can be extended to investigate various degeneracies in CIPN mechanisms to find therapeutic cures for it.
Tsai, Hsiu-Fen, and 蔡秀芬. "Exploring the Effects of Music Therapy on Pain, Fatigue, Anxiety, and Depression in Cancer Patients Undergoing Chemotherapy." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/us2w4s.
Повний текст джерелаRobarge, Jason Dennis. "Aromatase inhibitors produce hypersensitivity in experimental models of pain : studies in vivo and in isolated sensory neurons." Thesis, 2014. http://hdl.handle.net/1805/6056.
Повний текст джерелаAromatase inhibitors (AIs) are the current standard of care for the treatment of hormone receptor positive breast cancer in postmenopausal women. Nearly one-half of patients receiving AI therapy develop musculoskeletal toxicity that is characterized by joint and/or muscle pain and approximately one-fourth of patients discontinue their therapy as a result of musculoskeletal pain. Since there are no effective strategies for prevention or treatment, insight into the mechanisms of AI-induced pain is critical to improve treatment. However, there are few studies of AI effects in animal models of nociception. To determine whether AIs produce hypersensitivity in animal models of pain, I examined the effects of AI administration on mechanical, thermal, and chemical sensitivity in rats. The results demonstrate that (1) repeated injection of 5 mg/kg letrozole in male rats produces mechanical, but not thermal, hypersensitivity that extinguishes when drug dosing is stopped; (2) administering a single dose of 1 or 5 mg/kg letrozole in ovariectomized (OVX) rats also induces mechanical hypersensitivity, without altering thermal sensitivity and (3) a single dose of 5 mg/kg letrozole or daily dosing of letrozole or exemestane in male rats augments flinching behavior induced by intraplantar ATP injection. To determine whether the effects of AIs on nociceptive behaviors are mediated by activation or sensitization of peptidergic sensory neurons, I determined whether letrozole exposure alters release of calcitonin gene-related peptide (CGRP) from isolated rat sensory neurons and from sensory nerve endings in rat spinal cord slices. No changes in basal, capsaicin-evoked or high extracellular potassium-evoked CGRP release were observed in sensory neuronal cultures acutely or chronically exposed to letrozole. Furthermore, letrozole exposure did not alter the ability of ATP to augment CGRP release from sensory neurons in culture. Finally, chronic letrozole treatment did not augment neuropeptide release from spinal cord slices. Taken together, these results do not support altered release of this neuropeptide into the spinal cord as mediator of letrozole-induced mechanical hypersensitivity and suggest the involvement of other mechanisms. Results from this dissertation provide a new experimental model for AI-induced hypersensitivity that could be beneficial in delineating mechanisms mediating pain during AI therapy.
Lu, Ling-Chun, and 盧怜君. "The Relationships of Chemotherapy Induced Peripheral Neuropathic Pain, Activities of Daily Lives, Mood, and Quality of Life in Patient with Colorectal Cancers." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/43271838190560887976.
Повний текст джерела國立臺北護理健康大學
護理研究所
100
The purpose of this study was to investigate the relationships of chemotherarpy induced neuropathic pain, activies of daily lives, mood and quality of life among patients with colorectal cancer in Taiwan. A convenience sample was used in this cross-sectional study. The data was collected by self-administrated questionnaires. The instruments included Neuropathic Pain Symptom Inventory (NPSI)、Screening of Activity Limitation and Safety Aweareness Scale (SALSA scale)、Profile of Mood States short form (POMS SF)and Functional Assessment Cancer Therapy-Colorectal instruments version 4 (FACT-C version 4) as well as self-constructed items. A total of 106 questionnaires were distributed. The results revealed majority of the participants were male (53.8%) and married (77.4%). The average age was 56.92(SD=11.35). The level of education and occupation in most participants were senior high school (29.2%) and housekeeper (20.8%). The stage of cancer in most participants was stage III (60.4%) and IV (34.0%). There was history of chronic disease in the majority of the participants (63.2%) as well as history of post radical resection following by oxaliplatin/ 5-Fu-based chemotherapy (FOLFOX) (95.3%). On the incidence of chemotherapy induced neuropathic pain, majority of the participants is slight (93.4%). The severity of chemotherapy induced neuropathic pain from high to low was paraesthesia, intermittently neuropathic pain, induced neuropathic pain, and spontaneously neuropathic pain, subsequently. On the domain of activities of daily lives, minority of the participants is slight restriction (11.3%). The restrictive severity of activities of daily lives from high to low was self-care, work of hand, dexterity of hands and mobility of feet, subsequently. The score of each domain in mood from high to low was vigor-activity, confusion-bewilder, fatigue-inevtia, tension-anxiety, depression- dejection, and anger-hostility, subsequently. The results indicated that there were a low positive correlation between paraesthesia and dexterity of hands (r=.196, p<.05), a medium positive correlation between neuropathic pain and mood (r=.492, p<.001), a medium negative correlation between spontaneously neuropathic pain and quality of life (r=-.254, p<.01). In additional, a medium positive correlation between activities of daily lives and mood (r=.388, p<.01), a medium negative correlation between activities of daily lives and quality of life (r=-.328, p<.01) and a high negative correlation between mood and quality of life were reported (r=-.615, p<.001). Results from the hierarchical multiple regression analysis detected that stage, accumulative dose of chemotherapy, spontaneously neuropathic pain, and activies of daily lives were determinants in quality of life before mood was included. They can explained 45.2% of the variance on quality of life. Furthermore, the mediating effects of perceived mood on quality of life was analyzed by ordinary least square multiple regression analysis. The result showed 42.51% variance of spontaneously neuropathic pain on quality of life and 43.17% variance of activies of daily lives on quality of life could explained by perceived mood. The result from the current study may provide new insight into status and relationships of chemotherapy induced neuropathic pain, activies of daily lives, mood and quality of life among the patients with colorectal cancer. Strategies which aim to improve the quality of life among patients with colorectal cancer may be developed through the enhancement of nursing evaluation of chemotherapy induced neuropathic pain, activities of daily lives and mood, as well as strengthening management of care guideline.
Книги з теми "Cancer pain Chemotherapy"
Karen, Forbes, ed. Opioids in cancer pain. Oxford: Oxford University Press, 2007.
Знайти повний текст джерелаSociety, Canadian Cancer, ed. The pain manual: Principles and issues in cancer pain management. Montréal: Pegasus Healthcare, 1991.
Знайти повний текст джерелаStannard, Catherine F. Opioids in non-cancer pain. Oxford: Oxford University Press, 2007.
Знайти повний текст джерелаLogan, Marion. Continuous subcutaneous infusion of narcotics: Patient care and family support ; guide for CSCI nurses. Ottawa: University of Ottawa Press, 1991.
Знайти повний текст джерелаP, Squires Bruce, Canadian Cancer Society, and Canadian Association of Nurses in Oncology., eds. The pain manual: Principles and issues in cancer pain management. Montreal: Pegasus Healthcare International, 1997.
Знайти повний текст джерела1928-, Hill C. Stratton, and Fields William S. 1913-, eds. Drug treatment of cancer pain in a drug-oriented society. New York: Raven Press, 1989.
Знайти повний текст джерелаCardiff), Developing alternative models of care for pain management and cancer chemotherapy in Wales (1994. Developing alternative models of care for pain management and cancer chemotherapy in Wales: Proceedings of a seminar. Cardiff: Welsh Office, 1994.
Знайти повний текст джерелаA, Lack Sylvia, ed. Therapeutics in terminal cancer. Edinburgh: Churchill Livingstone, 1986.
Знайти повний текст джерелаA, Lack Sylvia, ed. Therapeutics in terminal cancer. 2nd ed. Edinburgh: Churchill Livingstone, 1990.
Знайти повний текст джерелаUnited States. Congress. Senate. A bill to establish a temporary program under which parenteral diacetylmorphine will be made available through qualified pharmacies for the relief of intractable pain due to cancer, and for other purposes. [Washington, D.C.?]: [United States Government Printing Office], 1993.
Знайти повний текст джерелаЧастини книг з теми "Cancer pain Chemotherapy"
Monfardini, S., and A. Scanni. "Chemotherapy and Radiotherapy for Cancer Pain." In Cancer Pain, 89–96. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-010-9139-8_8.
Повний текст джерелаResnick, Seth. "Cancer Pain Management, Chemotherapy." In Encyclopedia of Pain, 364–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-28753-4_527.
Повний текст джерелаGritsenko, Karina, and Michael Lubrano. "Chemotherapy." In Essentials of Interventional Cancer Pain Management, 19–27. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99684-4_4.
Повний текст джерелаAbrams, Ross A., and Richard M. Hansen. "Radiotherapy, Chemotherapy and Hormonal Therapy in the Management of Cancer Pain: Putting Patient, Prognosis, and Oncologic Options in Perspective." In Cancer Pain, 49–66. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0875-1_4.
Повний текст джерелаNersesyan, Hrachya, Jeffrey J. Mucksavage, Eljim Tesoro, and Konstantin V. Slavin. "Pain Management in Cancer Patients." In Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures, 437–52. Dordrecht: Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-9704-0_24.
Повний текст джерелаJamar, Susan Christensen. "Fatigue in Women Receiving Chemotherapy for Ovarian Cancer." In Management of Pain, Fatigue and Nausea, 224–28. London: Macmillan Education UK, 1989. http://dx.doi.org/10.1007/978-1-349-13397-0_28.
Повний текст джерелаVermorken, Jan B. "Where and when to Use Induction Chemotherapy in Head and Neck Squamous Cell Cancer." In Critical Issues in Head and Neck Oncology, 155–79. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_11.
Повний текст джерелаJAVLE, MILIND, and G. VARMA. "Chemotherapy for Cancer Pain Management." In Cancer Pain, 459–64. Elsevier, 2006. http://dx.doi.org/10.1016/b978-0-7216-0261-5.50041-7.
Повний текст джерелаCaplan, Rachel, and Kate Brizzi. "Chemotherapy-Induced Peripheral Neuropathy." In Pain, 269–76. Oxford University Press, 2022. http://dx.doi.org/10.1093/med/9780197542873.003.0032.
Повний текст джерелаMurtagh, Fliss E., and Irene J. Higginson. "Cancer neuropathic pain." In Neuropathic Pain, 75–83. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199563678.003.0009.
Повний текст джерелаТези доповідей конференцій з теми "Cancer pain Chemotherapy"
IPEK, Fulya, Vesile Yıldız Kabak, Songül Atasavun Uysal, and Tulin Duger. "AB0916 INVESTIGATION OF PAIN AND DEPRESSION IN CANCER OUTPATIENTS RECEIVING CHEMOTHERAPY." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8028.
Повний текст джерелаRosenzweig, Margaret Quinn, and Susan Wesmiller. "Abstract C11: Racial differential in pain and nausea during breast cancer chemotherapy." In Abstracts: Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 13-16, 2015; Atlanta, Georgia. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7755.disp15-c11.
Повний текст джерелаKumar, Siva. "Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685313.
Повний текст джерелаNascimento, Ranier Colbek, and Sabrina Ribas Freitas. "A 29-YEAR-OLD PREGNANT WOMAN WITH METASTATIC BREAST CANCER: A CASE REPORT." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2107.
Повний текст джерелаKumar, Siva. "Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685312.
Повний текст джерелаMaxwell, CL, AS Guinigundo, L. Vanni, PK Morrow, M. Reiner, A. Shih, Z. Klippel, and E. Blanchard. "Abstract P5-09-13: The effect of bone pain–specific education vs general chemotherapy side-effect education on reported bone pain in patients (pts) with breast cancer receiving chemotherapy and pegfilgrastim." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p5-09-13.
Повний текст джерелаGencheva, Nezabravka. "PHYSIOTHERAPY FOR COLON CANCER IN THE EARLY POSTOPERATIVE PERIOD - A CASE REPORT." In INTERNATIONAL SCIENTIFIC CONGRESS “APPLIED SPORTS SCIENCES”. Scientific Publishing House NSA Press, 2022. http://dx.doi.org/10.37393/icass2022/146.
Повний текст джерелаShin, Sarah, Jinhee Kim, Jin-Mu Yi, No Soo Kim, and Ok-Sun Bang. "Abstract B110: Assessments of ameliorative effect ofForsythia Fructuson chemotherapy-induced neuropathic pain and its genotoxic potential." In Abstracts: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; October 26-30, 2019; Boston, MA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1535-7163.targ-19-b110.
Повний текст джерелаSchwartzberg, L., M. Mo, R. Harms, and C. Vogel. "Reported Bone Pain in Patients with Breast Cancer Receiving Taxane-Based Chemotherapy in Clinical Trials of Pegfilgrastim." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-1117.
Повний текст джерелаBlebea, Nicoleta Mirela. "NUTRITIONAL THERAPY IN CLINICAL MANAGEMENT OF ONCOLOGICAL PATIENTS." In NORDSCI Conference Proceedings. Saima Consult Ltd, 2021. http://dx.doi.org/10.32008/nordsci2021/b1/v4/28.
Повний текст джерела